Drug-induced acute pancreatitis: A review

Ochsner Journal

Volumn 15, Issue 1, 2015, Pages 45-51

  Jones, Mark R ^a   Hall, Oliver Morgan ^a   Kaye, Adam M ^b   Kaye, Alan David ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

Angiotensin converting enzyme inhibitors; Antiretroviral therapy highly active; Diuretics; Hypoglycemic agents; Oral contraceptives; Pancreatitis; Statins; Valproic acid

Indexed keywords

ALOGLIPTIN; AMYLASE; ANTIDIABETIC AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENTEROPEPTIDASE; ENZYME PRECURSOR; GLUCAGON LIKE PEPTIDE 1 DERIVATIVE; HYDROCHLOROTHIAZIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 8; MACROLIDE; MEFENAMIC ACID; MESALAZINE; METHYLDOPA; METRONIDAZOLE; MIRTAZAPINE; MONTELUKAST; MYCOPHENOLIC ACID; ORAL CONTRACEPTIVE AGENT; PROTEINASE; SITAGLIPTIN; STIBOGLUCONATE SODIUM; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRYPSINOGEN; UNINDEXED DRUG; VALPROIC ACID;

ABDOMINAL TENDERNESS; ACUTE ABDOMEN; ACUTE PANCREATITIS; ALCOHOL ABUSE; ARTICLE; AUTOIMMUNE PANCREATITIS; CHOLESTASIS; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG RECHALLENGE; ECHOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; EPIGASTRIC PAIN; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HORMONE SUBSTITUTION; HUMAN; JAUNDICE; MEDICAL HISTORY; MENTAL DISEASE; MORBIDITY; MORTALITY; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; RESTLESSNESS; SEPSIS; SYMPTOM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; VOMITING;

EID: 84924664462     PISSN: 15245012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. VanWoerkom R, Adler DG. Acute pancreatitis: review and clinical update. Hosp Physician. 2009 Jan;45(1):9-19. http://www. turner-white.com/memberfile.php?PubCode¼hp_jan09_acute. pdf. Accessed October 29, 2014.
2. Vege SS, Yadav D, Chari ST. Pancreatitis. In: Talley NJ, Locke GR, Saito YA, eds. GI Epidemiology. Malden, MA: Blackwell Publishing; 2007.
3. McArthur KE. Review article: drug-induced pancreatitis. Aliment Pharmacol Ther. 1996 Feb;10(1):23-38.
4. Peery AF, Dellon ES, Lund J, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012 Nov;143(5):1179-1187.
5. Bradley EL 3rd. A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993 May;128(5):586-590.
6. Dervenis C, Johnson CD, Bassi C, et al. Diagnosis, objective assessment of severity, and management of acute pancreatitis. Int J Pancreatol. 1999 Jun;25(3):195-210.
7. Kitamoto Y, Yuan X, Wu Q, McCourt DW, Sadler JE. Enterokinase, the initiator of intestinal digestion, is a mosaic protease composed of a distinctive assortment of domains. Proc Natl Acad Sci USA. 1994 Aug 2;91(16):7588-7592.
8. Yamashina I. The action of enterokinase on trypsinogen. Biochim Biophys Acta. 1956 May;20(2):433-434.
9. Aoun E, Chang CC, Greer JB, Papachristou GI, Barmada MM, Whitcomb DC. Pathways to injury in chronic pancreatitis: decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis. PLoS One. 2008 Apr 16;3(4):e2003.
10. Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet. 2003 Sep;67(Pt 5):471-485.
11. Forsmark CE, Baillie J; AGA Institute Clinical Practice and Economics Committee; AGA Institute Governing Board. AGA Institute technical review on acute pancreatitis. Gastroenterology. 2007 May;132(5):2022-2044. Republished in: Rev Gastroenterol Mex. 2007 Jul-Sep;72(3):257-285.
12. Moreau JA, Zinsmeister AR, Melton LJ 3rd, DiMagno EP. Gallstone pancreatitis and the effect of cholecystectomy: a population-based cohort study. Mayo Clin Proc. 1988 May;63(5): 466-473.
13. Yang AL, Vadhavkar S, Singh G, Omary MB. Epidemiology of alcohol-related liver and pancreatic disease in the United States. Arch Intern Med. 2008 Mar 24;168(6):649-656.
14. Apte MV, Wilson JS, McCaughan GW, et al. Ethanol-induced alterations in messenger RNA levels correlate with glandular content of pancreatic enzymes. J Lab Clin Med. 1995 May; 125(5):634-640.
15. Tiscornia OM, Celener D, Perec CJ, De Lehmann ES, Cresta M, Dreiling DA. Physiopathogenic basis of alcoholic pancreatitis: the effects of elevated cholinergic tone and increased “pancreon” ecbolic response to CCK-PZ. Mt Sinai J Med. 1983 Sep-Oct; 50(5):369-387.
16. Toskes PP. Hyperlipidemic pancreatitis. Gastroenterol Clin North Am. 1990 Dec;19(4):783-791.
17. Mithöfer K, Fernández-del Castillo C, Frick TW, Lewandrowski KB, Rattner DW, Warshaw AL. Acute hypercalcemia causes acute pancreatitis and ectopic trypsinogen activation in the rat. Gastroenterology. 1995 Jul;109(1):239-246.
18. Wilmink T, Frick TW. Drug-induced pancreatitis. Drug Saf. 1996 Jun;14(6):406-423.
19. Badalov N, Baradarian R, Iswara K, Li J, Steinberg W, Tenner S. Drug-induced acute pancreatitis: an evidence-based review. Clin Gastroenterol Hepatol. 2007 Jun;5(6):648-667; quiz 644.
20. Sadr-Azodi O, Mattsson F, Bexlius TS, Lindblad M, Lagergren J, Ljung R. Association of oral glucocorticoid use with an increased risk of acute pancreatitis: a population-based nested case-control study. JAMA Intern Med. 2013 Mar 25;173(6):444-449.
21. Wilson RH, Moorehead RJ. Current management of trauma to the pancreas. Br J Surg. 1991 Oct;78(10):1196-1202.
22. Berg RA, Tarantino MD. Envenomation by the scorpion Centruroides exilicauda (C sculpturatus): severe and unusual manifestations. Pediatrics. 1991 Jun;87(6):930-933.
23. Parenti DM, Steinberg W, Kang P. Infectious causes of acute pancreatitis. Pancreas. 1996 Nov;13(4):356-371.
24. Aliperti G. Complications related to diagnostic and therapeutic endoscopic retrograde cholangiopancreatography. Gastrointest Endosc Clin N Am. 1996 Apr;6(2):379-407.
25. Bastid C, Bernard JP, Sarles H, Payan MJ, Sahel J. Mucinous ductal ectasia of the pancreas: a premalignant disease and a cause of obstructive pancreatitis. Pancreas. 1991 Jan;6(1):15-22.
26. Kaurich T. Drug-induced acute pancreatitis. Proc (Bayl Univ Med Cent). 2008 Jan;21(1):77-81.
27. Neoptolemos JP, Raraty M, Finch M, Sutton R. Acute pancreatitis: the substantial human and financial costs. Gut. 1998 Jun;42(6): 886-891.
28. Sekimoto M, Takada T, Kawarada Y, et al. JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg. 2006;13(1):10-24.
29. Silen W. Acute pancreatitis. In: Silen W, Cope Z, eds. Cope’s Early Diagnosis of the Acute Abdomen. 18th ed. New York, NY: Oxford University Press, 1999:123-131.
30. Mitchell RM, Byrne MF, Baillie J. Pancreatitis. Lancet. 2003 Apr 26;361(9367):1447-1455.
31. Swaroop VS, Chari ST, Clain JE. Severe acute pancreatitis. JAMA. 2004 Jun 16;291(23):2865-2868.
32. Dickson AP, Imrie CW. The incidence and prognosis of body wall ecchymosis in acute pancreatitis. Surg Gynecol Obstet. 1984 Oct;159(4):343-347.
33. Nadkarni NA, Khanna S, Vege SS. Splanchnic venous thrombosis and pancreatitis. Pancreas. 2013 Aug;42(6):924-931.
34. Morgan DE, Baron TH, Smith JK, Robbin ML, Kenney PJ. Pancreatic fluid collections prior to intervention: evaluation with MR imaging compared with CT and US. Radiology. 1997 Jun; 203(3):773-778.
35. Ranson JH, Turner JW, Roses DF, Rifkind KM, Spencer FC. Respiratory complications in acute pancreatitis. Ann Surg. 1974 May;179(5):557-566.
36. Ducarme G, Maire F, Chatel P, Luton D, Hammel P. Acute pancreatitis during pregnancy: a review. J Perinatol. 2014 Feb; 34(2):87-94.
37. De Bernardinis M, Violi V, Roncoroni L, Boselli AS, Giunta A, Peracchia A. Discriminant power and information content of Ranson’s prognostic signs in acute pancreatitis: a meta-analytic study. Crit Care Med. 1999 Oct;27(10):2272-2283.
38. Yadav D, Agarwal N, Pitchumoni CS. A critical evaluation of laboratory tests in acute pancreatitis. Am J Gastroenterol. 2002 Jun;97(6):1309-1318.
39. Spanier BW, Tuynman HA, van der Hulst RW, Dijkgraaf MG, Bruno MJ. Acute pancreatitis and concomitant use of pancreatitis-associated drugs. Am J Gastroenterol. 2011 Dec; 106(12):2183-2188.
40. Underwood TW, Frye CB. Drug-induced pancreatitis. Clin Pharm. 1993 Jun;12(6):440-448.
41. Griesbacher T. Kallikrein-kinin system in acute pancreatitis: potential of B(2)-bradykinin antagonists and kallikrein inhibitors. Pharmacology. 2000 Apr;60(3):113-120.
42. Thisted H, Jacobsen J, Munk EM, et al. Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther. 2006 Jan 1;23(1):185-190.
43. Frick TW, Speiser DE, Bimmler D, Largiadèr F. Drug-induced acute pancreatitis: further criticism. Dig Dis. 1993;11(2): 113-132.
44. Sinclair DB, Berg M, Breault R. Valproic acid-induced pancreatitis in childhood epilepsy: case series and review. J Child Neurol. 2004 Jul;19(7):498-502.
45. Alves C, Batel-Marques F, Macedo AF. A meta-analysis of serious adverse events reported with exenatide and liraglutide: acute pancreatitis and cancer. Diabetes Res Clin Pract. 2012 Nov; 98(2):271-284.
46. Faillie JL, Babai S, Crépin S, et al. Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database. Acta Diabetol. 2014 Jun;51(3):491-497.
47. Rouse R, Xu L, Stewart S, Zhang J. High fat diet and GLP-1 drugs induce pancreatic injury in mice. Toxicol Appl Pharmacol. 2014 Apr 15;276(2):104-114.
48. Vonlaufen A, Wilson JS, Apte MV. Molecular mechanisms of pancreatitis: current opinion. J Gastroenterol Hepatol. 2008 Sep; 23(9):1339-1348.
49. Denker PS, Dimarco PE. Exenatide (exendin-4)-induced pancreatitis: a case report. Diabetes Care. 2006 Feb;29(2):471.